New York med spa & injectable regulations
What’s changing for med spas and injectors in New York — GLP-1 compounding, scope-of-practice, and enforcement — plus the federal FDA and Federal Register actions that apply in New York. Med Spa Radar monitors it all and tells you, in plain language, what changed and what to do.
Opening a med spa? We have not verified New York’s rules against the statute yet, so start with what opening a med spa requires →
Latest New York changes
No New York-specific changes have crossed our radar yet — we’re actively monitoring the New York legislature and licensing boards. The federal changes below apply to every New York practice today.
Federal changes that apply in New York
FDA and Federal Register actions are nationwide — they govern New York practices too.
- CAUTIONFEDERALFederal RegisterJul 30, 2026
FDA / Federal Register Notice: Outsourcing Facility Fee Rates for Fiscal Year 2027
New FDA fees for outsourcing facilities will impact med spas using compounds.
- CRITICALFEDERALFDA Warning LetterJul 8, 2026
FDA Warning Letter: Spa De Soleil, Inc. (Drugs)
FDA warns Spa De Soleil over drug compounding practices.
- MONITORFEDERALFederal RegisterJun 26, 2026
FDA / Federal Register Notice: List of Bulk Drug Substances for Which There Is a Clinical Need Under Section 503B of the Federal Food, Drug, and Cosmetic Act; Extension of Comment Period
FDA extends comment period on GLP-1 compounding decisions.
- CRITICALFEDERALFDA Warning LetterJun 23, 2026
FDA Warning Letter: ketaminelab.org (Drugs)
FDA Warning Letter issued to ketaminelab.org for drugs.
- CRITICALFEDERALFTC EnforcementJun 12, 2026
FTC Files Contempt Motion Against Amare Global and Three Individuals Over Unsubstantiated Health Claims
FTC targets deceptive health claims affecting aesthetic practices.
- CAUTIONFEDERALFDA Drug ShortagesJun 11, 2026
FDA shortage: Liraglutide Injection (Injection) — Currently in Shortage
Liraglutide is still on the FDA shortage list for compounding.
What we monitor in New York
- New York legislature — bills on injectables, GLP-1s & scope of practice
- New York Board of Nursing — injector scope & delegation
- New York Medical Board — physician supervision & ownership rules
- New York Board of Pharmacy — compounding & 503A/503B
- U.S. FDA — enforcement, warning letters, recalls, shortages
- Federal Register — new rules on compounding & aesthetics
New York med spa compliance — FAQ
- Where do New York med spa and injectable regulations come from?
- New York med spas and injectors are governed by a mix of state and federal authorities — the New York legislature, and the state's boards of nursing, medicine, and pharmacy, alongside federal bodies like the FDA and the Federal Register. Med Spa Radar monitors all of them for New York and flags what changed in plain language.
- Does the FDA's GLP-1 compounding guidance apply in New York?
- Yes — federal FDA actions on GLP-1 compounding (semaglutide, tirzepatide) apply nationwide, including in New York. We track those federal changes alongside any New York-specific rules so you see the full picture for your practice.
- How do I keep up with New York regulatory changes?
- Med Spa Radar sends a free weekly Brief on what changed across New York, the FDA, and the Federal Register. Members get the exact "what to do" for their states in real time. It's regulatory monitoring, not legal advice.
Get New York changes as they publish
We scan the New York legislature and licensing boards daily, plus the FDA and the Federal Register. Free weekly Brief — what changed, in plain language, with the source.
Free · unsubscribe in one click · we never sell your address
← All states · Regulatory monitoring, not legal advice.